163 related articles for article (PubMed ID: 10694214)
1. Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats.
Marenco T; Bernstein S; Cumming P; Clarke PB
Br J Pharmacol; 2000 Jan; 129(1):147-55. PubMed ID: 10694214
[TBL] [Abstract][Full Text] [Related]
2. Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]-chlorisondamine.
el-Bizri H; Rigdon MG; Clarke PB
Br J Pharmacol; 1995 Nov; 116(5):2503-9. PubMed ID: 8581291
[TBL] [Abstract][Full Text] [Related]
3. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
Reuben M; Louis M; Clarke PB
Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.
Clarke PB; Chaudieu I; el-Bizri H; Boksa P; Quik M; Esplin BA; Capek R
Br J Pharmacol; 1994 Feb; 111(2):397-405. PubMed ID: 7911713
[TBL] [Abstract][Full Text] [Related]
5. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.
el-Bizri H; Clarke PB
Br J Pharmacol; 1994 Nov; 113(3):917-25. PubMed ID: 7858886
[TBL] [Abstract][Full Text] [Related]
6. Effects of nicotine on local cerebral glucose utilization in the rat.
London ED; Connolly RJ; Szikszay M; Wamsley JK; Dam M
J Neurosci; 1988 Oct; 8(10):3920-8. PubMed ID: 3193185
[TBL] [Abstract][Full Text] [Related]
7. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
Mellon RD; Bayer BM
J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
[TBL] [Abstract][Full Text] [Related]
8. Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks.
Chadman KK; Woods JH; Stitzel J
Nicotine Tob Res; 2007 Sep; 9(9):927-36. PubMed ID: 17763108
[TBL] [Abstract][Full Text] [Related]
9. Increased densities of monocarboxylate transport protein MCT1 after chronic administration of nicotine in rat brain.
Canis M; Mack B; Gires O; Maurer MH; Kuschinsky W; Duembgen L; Duelli R
Neurosci Res; 2009 Aug; 64(4):429-35. PubMed ID: 19433117
[TBL] [Abstract][Full Text] [Related]
10. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo.
el-Bizri H; Clarke PB
Br J Pharmacol; 1994 Feb; 111(2):414-8. PubMed ID: 8004385
[TBL] [Abstract][Full Text] [Related]
11. Local cerebral glucose utilization of the awake rat during chronic administration of nicotine.
Grünwald F; Schröck H; Theilen H; Biber A; Kuschinsky W
Brain Res; 1988 Jul; 456(2):350-6. PubMed ID: 3208084
[TBL] [Abstract][Full Text] [Related]
12. Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors.
Khokhar JY; Miksys SL; Tyndale RF
Brain Res; 2010 Aug; 1348():1-9. PubMed ID: 20599831
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.
Levant B; Pazdernik TL
Brain Res; 2004 Apr; 1003(1-2):159-67. PubMed ID: 15019575
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the reward-potentiating effects of nicotine on lateral hypothalamic brain stimulation by chlorisondamine.
Wise R; Marcangione C; Bauco P
Synapse; 1998 May; 29(1):72-9. PubMed ID: 9552176
[TBL] [Abstract][Full Text] [Related]
15. Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine.
Clarke PB
Br J Pharmacol; 1984 Oct; 83(2):527-35. PubMed ID: 6148986
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute administration of ethanol on cerebral glucose utilization in adult alcohol-preferring and alcohol-nonpreferring rats.
Strother WN; McBride WJ; Lumeng L; Li TK
Alcohol; 2005 Feb; 35(2):119-28. PubMed ID: 15963425
[TBL] [Abstract][Full Text] [Related]
17. Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms.
Caggiula AR; Epstein LH; Perkins KA; Saylor S
Psychopharmacology (Berl); 1995 Dec; 122(3):301-6. PubMed ID: 8748400
[TBL] [Abstract][Full Text] [Related]
18. The effect of an acute nicotine infusion on the local cerebral glucose utilization of the awake rat.
Grünwald F; Schröck H; Kuschinsky W
Klin Wochenschr; 1988; 66 Suppl 11():37-41. PubMed ID: 3184778
[TBL] [Abstract][Full Text] [Related]
19. Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats.
Bassant MH; Jazat-Poindessous F; Lamour Y
J Cereb Blood Flow Metab; 1996 Sep; 16(5):1014-25. PubMed ID: 8784247
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brain.
Hohmann AG; Matsumoto RR; Hemstreet MK; Patrick SL; Margulies JE; Hammer RP; Walker JM
Brain Res; 1992 Oct; 593(2):265-73. PubMed ID: 1450934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
